LTD.;AHN-GOOK PHARMACEUTICAL CO., LTD.;AHN-GOOK PHARMACEUTICAL CO.;안국약품 주식회사
发明人:
JEONG, HYEON GUN,정현근,LEE, JONG KWON,이종권,KIM, JONG GEOL,김종걸,KWON, DAE YONG,권대용,JEONG, HYEON GUNKR,LEE, JONG KWONKR,KIM, JONG GEOLKR,KWON, DAE YONGKR
申请号：
KR1020160110555
公开号：
KR1020180024408A
申请日:
2016.08.30
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention relates to a sustained release tablet containing cilostazol. More specifically, the present invention relates to a sustained release tablet containing cilostazol, composed of: cilostazol as an active material； polyethylene oxide which is a hydrophilic polymeric substance used as a sustained release base material； hypromellose； and microcrystalline cellulose as an insoluble diluting agent. The weight of a single tablet is less than or equal to 300 mg. According to the present invention, the sustained release tablet ensures excellent convenience in taking medicine.본 발명은 실로스타졸 함유 서방출성 정제에 관한 것으로서, 좀더 상세히 설명하면, 활성물질인 실로스타졸과, 서방화 기재로서 친수성 고분자 물질인 폴리에칠렌옥시드 및 히프로멜로오스, 그리고 난용성 부형제로서 미결정셀룰로스를 포함하여 이루어지며, 정제 한 개당 중량이 300mg 이하인 실로스타졸 함유 서방출성 정제에 관한 것이다.
